Biological Defense Market
Biological Defense Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Biological Defense Market Size and Growth
The Biological Defense market is projected to grow significantly, driven by rising bioterrorism threats and infectious disease outbreaks. The market size was valued at approximately $14 billion in 2023, with a compound annual growth rate (CAGR) of around 5%. Key players are focusing on advanced biodefense technologies and innovations.
Companies Covered
(Covid 19 Impact Covered)
◍ SIGA Technologies
◍ Ichor Medical Systems
◍ Emergent BioSolutions
◍ Elusys Therapeutics
◍ DynPort Vaccine Company
◍ Altimmune
◍ Cleveland BioLabs
◍ Bavarian Nordic
◍ Alnylam Pharmaceuticals
◍ Achaogen
◍ Alexeter Technologies
◍ ANP Technologies
◍ PathSensors
◍ New Horizons Diagnostics
◍ BBI Detection
The Biological Defense Market includes firms like SIGA Technologies and Emergent BioSolutions, focusing on biodefense products and therapies. Companies develop vaccines, therapeutics, and diagnostics to combat biothreats, driving market growth. Sales revenue for select firms:
- Emergent BioSolutions: $1.3 billion
- SIGA Technologies: $73 million
- Bavarian Nordic: $265 million. Request Sample Report
Market Segmentation
By Application
Military
Civilian
Other
Request Sample Report
By Product
Anthrax
Small Pox
Radiation / Nuclear
Other
$ 60.48 Billion
Request Sample Report
